Breast Cancer Product Details

Pretomanid Tablets

Model: Manufacturer
|
Category: Other

Hongqi pharmaceutical

Quick Info

tuberculosis

Description
Specification Features
Dosage Administration
Faqs

This product is an antimycobacterial drug indicated as part of a combination therapy with bedaquiline and linezolid for the treatment of adult patients with pulmonary tuberculosis (TB) resistant to isoniazid, rifamycins, any fluoroquinolone, and any second-line injectable anti-TB drug, or resistant to isoniazid and rifampicin who are intolerant or unresponsive to standard treatment. This indication is approved based on limited clinical safety and efficacy data. This product is only indicated for limited and specific patient populations.

200mg

This product can only be used in combination with bedaquiline and linezolid as part of combination therapy.
This product should be administered and monitored by a physician experienced in treating multidrug-resistant tuberculosis.
The importance of full treatment compliance should be emphasized to patients.
This product should be used in combination with bedaquiline and linezolid under directly supervised treatment (DOT).

The safety and efficacy of this product as part of a combination therapy with other drugs other than bedaquiline and linezolid have not been established. Therefore, this product should not be used as part of other combination therapy regimens. This product is used as part of a combination therapy with bedaquiline and linezolid. For more risk information, please refer to the instructions for bedaquiline and linezolid. The precautions related to bedaquiline and linezolid also apply to their combination therapy with this product.

×